Know Cancer

or
forgot password

Critical Role of MicroRNA-34a and MicroRNA-194 in Acute Myeloid Leukemia With CEBPA Mutations


N/A
N/A
N/A
Not Enrolling
Both
Leukemia

Thank you

Trial Information

Critical Role of MicroRNA-34a and MicroRNA-194 in Acute Myeloid Leukemia With CEBPA Mutations


OBJECTIVES:

- To determine the significance of regulation of microRNA-34a and microRNA-194 by C/EBPα
during granulopoiesis in patients with acute myeloid leukemia with CEBPA mutations.

- To determine whether overexpression of micro RNA-34a and microRNA-194 in myeloid
progenitors with C/EBPα mutations leads to granulocytic differentiation.

- To examine how microRNA-34a and microRNA-194 downregulate E2F3 during granulopoiesis.

- To determine the role of microRNA-34a and microRNA-194 in myeloid cell proliferation.

OUTLINE: Cryopreserved cell samples are collected for laboratory analysis, including
mutation analysis, gene expression analysis, RNA analysis, and fluorescence-activated cell
sorting (FACS) analysis.

Inclusion Criteria


DISEASE CHARACTERISTICS:

- Diagnosis of acute myeloid leukemia with CEBPA mutations

PATIENT CHARACTERISTICS:

- Not specified

PRIOR CONCURRENT THERAPY:

- Not specified

Type of Study:

Observational

Study Design:

N/A

Outcome Measure:

Significance of regulation of microRNA-34a and microRNA-194 by C/EBPα during granulopoiesis

Safety Issue:

No

Principal Investigator

Soheil Meshinchi, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Fred Hutchinson Cancer Research Center

Authority:

United States: Federal Government

Study ID:

CDR0000664229

NCT ID:

NCT01057199

Start Date:

January 2010

Completion Date:

Related Keywords:

  • Leukemia
  • adult acute myeloid leukemia
  • childhood acute myeloid leukemia/other myeloid malignancies
  • Leukemia
  • Leukemia, Myeloid, Acute
  • Leukemia, Myeloid

Name

Location